PubMed:15389972
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-57 | Sentence | denotes | Etiology of Paget's disease and osteoclast abnormalities. |
| TextSentencer_T2 | 58-186 | Sentence | denotes | Paget's disease of bone is a chronic focal skeletal disorder that affects up to 2-3% of the population over the age of 60 years. |
| TextSentencer_T3 | 187-244 | Sentence | denotes | Paget's disease is primarily a disease of the osteoclast. |
| TextSentencer_T4 | 245-424 | Sentence | denotes | The pathologic abnormality in patients with Paget's disease involves increased bone resorption by the osteoclasts, followed by abundant new bone formation that is of poor quality. |
| TextSentencer_T5 | 425-581 | Sentence | denotes | Genetic linkage analysis indicated that 40% of patients with Paget's disease have an affected first degree relative and 1% of patients develop osteosarcoma. |
| TextSentencer_T6 | 582-656 | Sentence | denotes | Paget's disease is an autosomal dominant trait with genetic heterogeneity. |
| TextSentencer_T7 | 657-797 | Sentence | denotes | Recurrent mutations in the ubiquitin-associated (UBA) domain of sequestosome 1 (SQSTM1/p62) are identified in patients with Paget's disease. |
| TextSentencer_T8 | 798-972 | Sentence | denotes | Osteoclasts and osteoclast precursors from patients with Paget's disease contain paramyxoviral transcripts and appear hyperresponsive to 1,25-(OH)2D3 and RANK ligand (RANKL). |
| TextSentencer_T9 | 973-1164 | Sentence | denotes | It has been suggested that the enhanced sensitivity of osteoclast precursors for 1,25-(OH)2D3 in Paget's disease results from increased expression of coactivators of vitamin D receptor (VDR). |
| TextSentencer_T10 | 1165-1338 | Sentence | denotes | However, a cause and effect relationship for the paramyxoviral infection and SQSTM1/p62 gene mutations associated with this disease and osteoclast abnormalities are unclear. |
| TextSentencer_T11 | 1339-1400 | Sentence | denotes | Therefore, the etiology of Paget's disease remains uncertain. |
| T1 | 0-57 | Sentence | denotes | Etiology of Paget's disease and osteoclast abnormalities. |
| T2 | 58-186 | Sentence | denotes | Paget's disease of bone is a chronic focal skeletal disorder that affects up to 2-3% of the population over the age of 60 years. |
| T3 | 187-244 | Sentence | denotes | Paget's disease is primarily a disease of the osteoclast. |
| T4 | 245-424 | Sentence | denotes | The pathologic abnormality in patients with Paget's disease involves increased bone resorption by the osteoclasts, followed by abundant new bone formation that is of poor quality. |
| T5 | 425-581 | Sentence | denotes | Genetic linkage analysis indicated that 40% of patients with Paget's disease have an affected first degree relative and 1% of patients develop osteosarcoma. |
| T6 | 582-656 | Sentence | denotes | Paget's disease is an autosomal dominant trait with genetic heterogeneity. |
| T7 | 657-797 | Sentence | denotes | Recurrent mutations in the ubiquitin-associated (UBA) domain of sequestosome 1 (SQSTM1/p62) are identified in patients with Paget's disease. |
| T8 | 798-972 | Sentence | denotes | Osteoclasts and osteoclast precursors from patients with Paget's disease contain paramyxoviral transcripts and appear hyperresponsive to 1,25-(OH)2D3 and RANK ligand (RANKL). |
| T9 | 973-1164 | Sentence | denotes | It has been suggested that the enhanced sensitivity of osteoclast precursors for 1,25-(OH)2D3 in Paget's disease results from increased expression of coactivators of vitamin D receptor (VDR). |
| T10 | 1165-1338 | Sentence | denotes | However, a cause and effect relationship for the paramyxoviral infection and SQSTM1/p62 gene mutations associated with this disease and osteoclast abnormalities are unclear. |
| T11 | 1339-1400 | Sentence | denotes | Therefore, the etiology of Paget's disease remains uncertain. |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 15389972-6#64#78#gene8878 | 721-735 | gene8878 | denotes | sequestosome 1 |
| 15389972-6#80#86#gene8878 | 737-743 | gene8878 | denotes | SQSTM1 |
| 15389972-6#124#139#diseaseC0029401 | 781-796 | diseaseC0029401 | denotes | Paget's disease |
| 15389972-6#124#139#diseaseC1368019 | 781-796 | diseaseC1368019 | denotes | Paget's disease |
| 15389972-6#124#139#diseaseC0029401 | 781-796 | diseaseC0029401 | denotes | Paget's disease |
| 15389972-6#124#139#diseaseC1368019 | 781-796 | diseaseC1368019 | denotes | Paget's disease |
| 15389972-7#154#158#gene8792 | 952-956 | gene8792 | denotes | RANK |
| 15389972-7#57#72#diseaseC0029401 | 855-870 | diseaseC0029401 | denotes | Paget's disease |
| 15389972-7#57#72#diseaseC1368019 | 855-870 | diseaseC1368019 | denotes | Paget's disease |
| 15389972-8#166#184#gene7421 | 1139-1157 | gene7421 | denotes | vitamin D receptor |
| 15389972-8#186#189#gene7421 | 1159-1162 | gene7421 | denotes | VDR |
| 15389972-8#97#112#diseaseC0029401 | 1070-1085 | diseaseC0029401 | denotes | Paget's disease |
| 15389972-8#97#112#diseaseC1368019 | 1070-1085 | diseaseC1368019 | denotes | Paget's disease |
| 15389972-8#97#112#diseaseC0029401 | 1070-1085 | diseaseC0029401 | denotes | Paget's disease |
| 15389972-8#97#112#diseaseC1368019 | 1070-1085 | diseaseC1368019 | denotes | Paget's disease |
| 64#78#gene8878124#139#diseaseC0029401 | 15389972-6#64#78#gene8878 | 15389972-6#124#139#diseaseC0029401 | associated_with | sequestosome 1,Paget's disease |
| 64#78#gene8878124#139#diseaseC1368019 | 15389972-6#64#78#gene8878 | 15389972-6#124#139#diseaseC1368019 | associated_with | sequestosome 1,Paget's disease |
| 64#78#gene8878124#139#diseaseC0029401 | 15389972-6#64#78#gene8878 | 15389972-6#124#139#diseaseC0029401 | associated_with | sequestosome 1,Paget's disease |
| 64#78#gene8878124#139#diseaseC1368019 | 15389972-6#64#78#gene8878 | 15389972-6#124#139#diseaseC1368019 | associated_with | sequestosome 1,Paget's disease |
| 80#86#gene8878124#139#diseaseC0029401 | 15389972-6#80#86#gene8878 | 15389972-6#124#139#diseaseC0029401 | associated_with | SQSTM1,Paget's disease |
| 80#86#gene8878124#139#diseaseC1368019 | 15389972-6#80#86#gene8878 | 15389972-6#124#139#diseaseC1368019 | associated_with | SQSTM1,Paget's disease |
| 80#86#gene8878124#139#diseaseC0029401 | 15389972-6#80#86#gene8878 | 15389972-6#124#139#diseaseC0029401 | associated_with | SQSTM1,Paget's disease |
| 80#86#gene8878124#139#diseaseC1368019 | 15389972-6#80#86#gene8878 | 15389972-6#124#139#diseaseC1368019 | associated_with | SQSTM1,Paget's disease |
| 154#158#gene879257#72#diseaseC0029401 | 15389972-7#154#158#gene8792 | 15389972-7#57#72#diseaseC0029401 | associated_with | RANK,Paget's disease |
| 154#158#gene879257#72#diseaseC1368019 | 15389972-7#154#158#gene8792 | 15389972-7#57#72#diseaseC1368019 | associated_with | RANK,Paget's disease |
| 166#184#gene742197#112#diseaseC0029401 | 15389972-8#166#184#gene7421 | 15389972-8#97#112#diseaseC0029401 | associated_with | vitamin D receptor,Paget's disease |
| 166#184#gene742197#112#diseaseC1368019 | 15389972-8#166#184#gene7421 | 15389972-8#97#112#diseaseC1368019 | associated_with | vitamin D receptor,Paget's disease |
| 166#184#gene742197#112#diseaseC0029401 | 15389972-8#166#184#gene7421 | 15389972-8#97#112#diseaseC0029401 | associated_with | vitamin D receptor,Paget's disease |
| 166#184#gene742197#112#diseaseC1368019 | 15389972-8#166#184#gene7421 | 15389972-8#97#112#diseaseC1368019 | associated_with | vitamin D receptor,Paget's disease |
| 186#189#gene742197#112#diseaseC0029401 | 15389972-8#186#189#gene7421 | 15389972-8#97#112#diseaseC0029401 | associated_with | VDR,Paget's disease |
| 186#189#gene742197#112#diseaseC1368019 | 15389972-8#186#189#gene7421 | 15389972-8#97#112#diseaseC1368019 | associated_with | VDR,Paget's disease |
| 186#189#gene742197#112#diseaseC0029401 | 15389972-8#186#189#gene7421 | 15389972-8#97#112#diseaseC0029401 | associated_with | VDR,Paget's disease |
| 186#189#gene742197#112#diseaseC1368019 | 15389972-8#186#189#gene7421 | 15389972-8#97#112#diseaseC1368019 | associated_with | VDR,Paget's disease |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2148 | 721-735 | gene:8878 | denotes | sequestosome 1 |
| T2149 | 781-796 | disease:C0029401 | denotes | Paget's disease |
| T2150 | 737-743 | gene:8878 | denotes | SQSTM1 |
| T2151 | 952-956 | gene:8792 | denotes | RANK |
| T2152 | 855-870 | disease:C0029401 | denotes | Paget's disease |
| T2153 | 1139-1157 | gene:7421 | denotes | vitamin D receptor |
| T2154 | 1070-1085 | disease:C0029401 | denotes | Paget's disease |
| T2155 | 1159-1162 | gene:7421 | denotes | VDR |
| R1 | T2148 | T2149 | associated_with | sequestosome 1,Paget's disease |
| R2 | T2148 | T2149 | associated_with | sequestosome 1,Paget's disease |
| R3 | T2150 | T2149 | associated_with | SQSTM1,Paget's disease |
| R4 | T2150 | T2149 | associated_with | SQSTM1,Paget's disease |
| R5 | T2151 | T2152 | associated_with | RANK,Paget's disease |
| R6 | T2151 | T2152 | associated_with | RANK,Paget's disease |
| R7 | T2153 | T2154 | associated_with | vitamin D receptor,Paget's disease |
| R8 | T2153 | T2154 | associated_with | vitamin D receptor,Paget's disease |
| R9 | T2155 | T2154 | associated_with | VDR,Paget's disease |
| R10 | T2155 | T2154 | associated_with | VDR,Paget's disease |